Berend-Jan Bosch

Berend-Jan Bosch

Auto-generated profile, based on publicly available information

Berend-Jan Bosch

Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2013 in Nature
Verified
Journal Article
Closed access
DRDr. V. Stalin Raj
Dr. V. Stalin Raj
HMHuihui Mou
Huihui Mou
SSSaskia L. Smits
Saskia L. Smits
DDDick H. W. Dekkers
Dick H. W. Dekkers
MMMarcel A. Müller
Marcel A. Müller
BHBart Haagmans
Bart Haagmans

4 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CWChunyan Wang
Chunyan Wang
Wentao LiWentao Li
Wentao Li
DDDubravka Drabek
Dubravka Drabek
NONisreen Okba
Nisreen Okba
RHRien van Haperen
Rien van Haperen
BBBerend-Jan Bosch
Berend-Jan Bosch
The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.

1 January 2016
Verified
Book Chapter
Closed access
RHRuben Hulswit
Ruben Hulswit
CHCornelis De Haan
Cornelis De Haan
BBB.-J. Bosch
B.-J. Bosch

12 September 2016 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
AWAlexandra C Walls
Alexandra C Walls
MTM Alejandra Tortorici
M Alejandra Tortorici
BFBrandon Frenz
Brandon Frenz
JSJoost Snijder
Joost Snijder
Wentao LiWentao Li
Wentao Li
DVDavid Veesler
David Veesler

18 September 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Wentao LiWentao Li
Wentao Li
RHRuben Hulswit
Ruben Hulswit
IWIvy Widjaja
Ivy Widjaja
DRDr. V. Stalin Raj
Dr. V. Stalin Raj
RMRyan McBride
Ryan McBride
BBBerend-Jan Bosch
Berend-Jan Bosch
Middle East respiratory syndrome coronavirus (MERS-CoV) targets the epithelial cells of the respiratory tract both in humans and in its natural host, the dromedary camel. Virion attachment to host cells is mediated by 20-nm-long homotrimers of spike envelope protein S. The N-terminal subunit of each S protomer, called S1, folds into four distinct domains designated S1A through S1D. Binding of MERS-CoV to the cell surface entry receptor dipeptidyl peptidase 4 (DPP4) occurs via S1B. We now demonstrate that in addition to DPP4, MERS-CoV binds to sialic acid (Sia). Initially demonstrated by hemagglutination assay with human erythrocytes and intact virus, MERS-CoV Sia-binding activity was assigned to S subdomain S1A. When multivalently displayed on nanoparticles, S1 or S1A bound to human erythrocytes and to human mucin in a strictly Sia-dependent fashion. Glycan array analysis revealed a preference for α2,3-linked Sias over α2,6-linked Sias, which correlates with the differential distribution of α2,3-linked Sias and the predominant sites of MERS-CoV replication in the upper and lower respiratory tracts of camels and humans, respectively. Binding is hampered by Sia modifications such as 5-N-glycolylation and (7,)9-O-acetylation. Depletion of cell surface Sia by neuraminidase treatment inhibited MERS-CoV entry of Calu-3 human airway cells, thus providing direct evidence that virus–Sia interactions may aid in virion attachment. The combined observations lead us to propose that high-specificity, low-affinity attachment of MERS-CoV to sialoglycans during the preattachment or early attachment phase may form another determinant governing the host range and tissue tropism of this zoonotic pathogen.

14 May 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Wentao LiWentao Li
Wentao Li
RHRuben Hulswit
Ruben Hulswit
Scott KenneyScott Kenney
Scott Kenney
IWIvy Widjaja
Ivy Widjaja
KJKwonil Jung
Kwonil Jung
BBBerend-Jan Bosch
Berend-Jan Bosch
Porcine deltacoronavirus (PDCoV), identified in 2012, is a common enteropathogen of swine with worldwide distribution. The source and evolutionary history of this virus is, however, unknown. PDCoV belongs to the Deltacoronavirus genus that comprises predominantly avian CoV. Phylogenetic analysis suggests that PDCoV originated relatively recently from a host-switching event between birds and mammals. Insight into receptor engagement by PDCoV may shed light into such an exceptional phenomenon. Here we report that PDCoV employs host aminopeptidase N (APN) as an entry receptor and interacts with APN via domain B of its spike (S) protein. Infection of porcine cells with PDCoV was drastically reduced by APN knockout and rescued after reconstitution of APN expression. In addition, we observed that PDCoV efficiently infects cells of unusual broad species range, including human and chicken. Accordingly, PDCoV S was found to target the phylogenetically conserved catalytic domain of APN. Moreover, transient expression of porcine, feline, human, and chicken APN renders cells susceptible to PDCoV infection. Binding of PDCoV to an interspecies conserved site on APN may facilitate direct transmission of PDCoV to nonreservoir species, including humans, potentially reflecting the mechanism that enabled a virus, ancestral to PDCoV, to breach the species barrier between birds and mammals. The APN cell surface protein is also used by several members of the Alphacoronavirus genus. Hence, our data constitute the second identification of CoVs from different genera that use the same receptor, implying that CoV receptor selection is subjected to specific restrictions that are still poorly understood. Significance Coronaviruses exhibit a propensity for interspecies transmission, with SARS- and MERS-coronaviruses as notable examples. Cross-species transmission by coronaviruses is foremost determined by the virus’ ability to bind receptors of new hosts. We here report that the recently identified, yet globally distributed porcine deltacoronavirus employs host aminopeptidase N (APN) as an entry receptor via S protein-mediated interaction with an interspecies conserved domain that allows for APN orthologue-mediated entry. Identification of APN as a deltacoronavirus receptor emphasizes the remarkable preferential employment of cell surface host peptidases as receptors by coronaviruses. Our findings provide important insight into how receptor usage of coronaviruses may fuel cross-host transmission between distantly related species and necessitate surveillance studies of deltacoronaviruses in thus far unappreciated potential reservoirs, including humans.